You are here

Press Releases

July 23, 2014
Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, issued the following statement on today’s House Energy and Commerce Committee 21st Century Cures... Read More
March 31, 2014
Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on congressional passage of important diagnostics payment... Read More
January 27, 2014
AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that develop and manufacture diagnostic tests, has elected John L. Bishop, chairman and chief... Read More
October 23, 2013
A new website, Unlocking Answers: A Key to Your Health Care Diagnosis, launched today to provide users with resources that they can use to better understand the diagnostic tests that they receive. Diagnostic tests play an essential role in America’s... Read More
October 9, 2013
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that develop and manufacture diagnostic tests, has elected several new members... Read More
September 12, 2013
Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the introduction in the U.S. House of Representatives of the... Read More
September 6, 2013
Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, issued the following statement in advance of next week’s Diabetes Technology Society meeting in... Read More
July 9, 2013
AdvaMedDx applauds the New York Times on its July 7th editorial urging FDA review of high-risk laboratory developed tests. For more information on the risk based approach to regulation of diagnostic tests, please click here. For more information,... Read More
June 18, 2013
Boston, MA and Washington, DC – DxInsights, a nonprofit, independent organization devoted to educating stakeholders on the value and power of diagnostics and AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) representing... Read More
June 12, 2013
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement regarding the report issued by the... Read More

Pages